Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft

International Immunopharmacology

Volumn 5, Issue 2, 2005, Pages 417-425

  Zhang, Jian ^a,b   Sun, Rui ^a,b   Wei, Haiming ^b   Tian, Zhigang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Adenocarcinoma; Human NK cell; Prolactin; SCID mice; Xenograft

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; PROLACTIN; RECOMBINANT HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER MORTALITY; CANCER SURVIVAL; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN HT29; COCULTURE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; REVIEW; SUPERNATANT; SURVIVAL RATE; TIME; TUMOR GROWTH; XENOGRAFT;

EID: 12344329608     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.10.008     Document Type: Article

References (54)

1. B.C. Cunningham, M. Ultsch, A.M. DeVos, M.G. Mulkerrin, K.R. Clauser, and J.A. Wells Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule Science 254 1991 821 826
2. E. Thoreau, B. Petridou, P.A. Kelly, J. Djiane, and J.P. Mornon Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis FEBS Lett. 282 1991 26 31
3. L. Matera Endocrine, paracrine and autocrine actions of prolactin on immune cells Life Sci. 59 1996 599 614
4. W.J. Murphy, Rui Hallgeir, and D.L. Longo Effects of growth hormone and prolactin: immune development and function Life Sci. 57 1995 1 14
5. I.C. Chikanza Prolactin and neuroimmunomodulation: in vitro and in vivo observations Ann. N. Y. Acad. Sci. 876 1999 119 130
6. S.M. Richards, and W.J. Murphy Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function J. Neuroimmunol. 109 2000 56 62
7. R.R. Gala, and E.M. Shevach Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse Endocrinology 133 1993 617 1623
8. M.C. Gagnerault, P. Touraine, W. Savino, P.A. Kelly, and M. Dardenne Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations J. Immunol. 150 1993 5673 5681
9. M.B. Prystowsky, and C.V. Clevenger Prolactin as a second messenger for interleukin 2 Immunomethods 5 1994 49 55
10. R. Di Carlo, C. Bole-Feysot, O. Gualillo, R. Meli, M. Nagano, and P.A. Kelly Regulation of prolactin receptor mRNA expression in peripheral lymphocytes in rats in response to changes in serum concentrations of prolactin Endocrinology 136 1995 4713 4716
11. L. Matera, M. Geuna, C. Pastore, S. Buttiglieri, G. Gaidano, and A. Savarino Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells Int. J. Cancer 85 2000 124 130
12. H. Gunes, and A.M. Mastro Prolactin receptor gene expression in rat splenocytes and thymocytes during oestrous cycle, pregnancy and lactation Cell Prolif. 30 1997 219 235
13. H. Gunes, S. Zawilla, and A.M. Mastro Prolactin receptor expression by splenocytes from rats in various hormonal states Cell Prolif. 30 1997 127 137
14. H. Gunes, and A.M. Mastro Prolactin receptor gene expression in rat splenocytes and thymocytes from birth to adulthood Mol. Cell. Endocrinol. 117 1996 41 52
15. M.C. Leite-de-Moraes, P. Touraine, P.A. Kelly, F. Kuttenn, and M. Dardenne Prolactin receptor expression in lymphocytes from patients with hyperprolactinemia or acromegaly J. Endocrinol. 147 1995 353 359
16. M. Dardenne, M. do C. de Moraes, P.A. Kelly, and M.C. Gagnerault Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry Endocrinology 34 1994 2108 2114
17. M. Neidhart Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion Biomed. Pharmacother. 51 1997 118 125
18. A. Vidaller, F. Guadarrama, L. Llorente, J.B. Mendez, F. Larrea, and A.R. Villa Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient J. Clin. Immunol. 12 1992 210 215
19. W.J. Murphy, S.K. Durum, M.R. Anver, and D.L. Longo Immunological and haematological effects of neuroendocrine hormone: studies on DW/J dwarf mice J. Immunol. 148 1992 3799 3808
20. P. Morales, M.V. Carretero, H. Geronimo, S.G. Copin, M.L. Gaspar, and M.A. Marcos Influence of prolactin on the differentiation of mouse B-lymphoid precursors Cell Growth Differ. 10 1999 583 590
21. B. Bouchard, C.J. Ormandy, J.P. Di Santo, and P.A. Kelly Immune system development and function in prolactin receptor-deficient mice J. Immunol. 163 1999 576 582
22. S.M. Richards, R.D. Garman, L. Keyes, B. Kavanagh, and J.M. McPherson Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas Cell. Immunol. 184 1998 85 91
23. W.H. Chambers, A.A. Amoscato, M.S. Smith, T.W. Kenniston, R.B. Herberman, and P.M. Appasamy Prolactin receptor expression by rat NK cells Nat. Immun. 14 1995 145 156
24. L. Matera, M. Contarini, G. Bellone, B. Forno, and A. Biglino Up-modulation of interferon-gamma mediates the enhancement of spontaneous cytotoxicity in prolactin-activated natural killer cells Immunology 98 1999 386 392
25. G. Gaidano, M. Contarini, C. Pastore, G. Saglio, and L. Matera AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin Proc. Soc. Exp. Biol. Med. 213 1996 196 205
26. M. Provinciali, G. Di Stefano, S. Stronati, W. Raffaeli, G. Pari, and N. Fabris Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients Int. J. Immunopharmacol. 18 1996 577 586
27. A. Chakraborty, N.G. Chakraborty, and U. Chattopadhyay Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavity and during aging Int. J. Cancer 66 1996 65 69
28. E. Oberholtzer, M. Contarini, F. Veglia, A. Cossarizza, C. Franceschi, and M. Geuna Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors Adv. Neuroimmunol. 6 1996 233 247
29. M. Provinciali, G. Di Stefano, M. Muzzioli, G.G. Garzetti, A. Ciavattini, and N. Fabris Relationship between 17-beta-estradiol and prolactin in the regulation of natural killer cell activity during progression of endometriosis J. Endocrinol. Invest. 18 1995 645 652
30. A. Cesano, E. Oberholtzer, M. Contarini, M. Geuna, G. Bellone, and L. Matera Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors Immunopharmacology 28 1994 67 75
31. L. Matera, A. Cesano, G. Bellone, and E. Oberholtzer Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes Brain Behav. Immun. 6 1992 409 417
32. L. Matera, G. Bellone, and M. Contarini Synthesis of a prolactin-like peptide by natural killer cells: positive regulation by CD16 and exogenous prolactin Cell. Mol. Biol. 38 1992 915 920
33. G. Bellone, M. Geuna, A. Carbone, S. Silvestri, R. Foa, and G. Emanuelli Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells J. Cell. Physiol. 163 1995 221 231
34. C.V. Clevenger, D.O. Freier, and J.B. Kline Prolactin receptor signal transduction in cells of the immune system J. Endocrinol. 157 1998 187 197
35. F. Gouilleux, D. Moritz, M. Humar, R. Moriggl, S. Berchtold, and B. Groner Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor Endocrinology 136 1995 5700 5708
36. A.R. Buckley, Y.P. Rao, D.J. Buckley, and P.W. Gout Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cells Biochem. Biophys. Res. Commun. 204 1994 1158 1164
37. H. Rui, R.A. Kirken, and W.L. Farrar Activation of receptor-associated tyrosine kinase JAK2 by prolactin J. Biol. Chem. 269 1994 5364 5368
38. D.W. Montgomery, J.S. Krumenacker, and A.R. Buckley Prolactin stimulates phosphorylation of the human T-cell antigen receptor complex and ZAP-70 tyrosine kinase: a potential mechanism for its immunomodulation Endocrinology 139 1998 811 814
39. G.S. Campbell, L.S. Argetsinger, J.N. Ihle, P.A. Kelly, J.A. Rillema, and C. Carter-Su Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants Proc. Natl. Acad. Sci. U. S. A. 91 1994 5232 5236
40. R. Sun, J. Fan, H. Wei, C. Zhang, and Z. Tian Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: comparison with interleukin-2 J. Immunol. Methods 279 2003 79 90
41. M.A. Woody, L.A. Welniak, R. Sun, Z.G. Tian, M. Henry, and S. Richards Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine Exp. Hematol. 27 1999 811 816
42. Z.G. Tian, M.A. Woody, R. Sun, L.A. Welniak, A. Raziuddin, and S. Funakoshi Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice Stem. Cells 16 1998 193 199
43. O. Asai, D.L. Longo, Z.G. Tian, R.L. Hornung, D.D. Taub, and F.W. Ruscetti Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation J. Clin. Invest. 101 1998 1835 1842
44. W.J. Murphy, Z.G. Tian, O. Asai, S. Funakoshi, P. Rotter, and M. Henry Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice J. Immunol. 156 1996 2104 2111
45. W.J. Murphy, D.D. Taub, and D.L. Longo The huPBL-SCID mouse as a means to examine human immune function in vivo Semin. Immunol. 8 1996 233 241
46. M.A. Woody, L.A. Welniak, S. Richards, D.D. Taub, Z. Tian, and R. Sun Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation Neuroimmunomodulation 6 1999 69 80
47. L.A. Welniak, Z.G. Tian, R. Sun, J.R. Keller, S. Richards, and F.W. Ruscetti Effects of growth hormone and prolactin on hematopoiesis Leuk. Lymphoma. 38 2000 435 445
48. R. Sun, A.L. Li, H.M. Wei, and Z.G. Tian Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines Cell Res. 14 2004 67 73
49. Z.G. Tian, D.L. Longo, S. Funakoshi, O. Asai, D.K. Ferris, and M. Widmer In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts Cancer Res. 55 1995 5335 5341
50. M. Llovera, C. Pichard, S. Bernichtein, S. Jeay, P. Touraine, and P.A. Kelly Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation Oncogene 19 2000 4695 4705
51. X. Xu, E. Kreye, C.B. Kuo, and A.M. Walker A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice Cancer Res. 61 2001 6098 6104
52. D.B. Agus, C.D. Surh, and J. Sprent Reentry of T cells to the adult thymus is restricted to activated T cells J. Exp. Med. 173 1991 1039 1046
53. W.J. Murphy, S.K. Durum, and D.L. Longo Human growth hormone promotes engraftment of murine or human T cell into severe combined immunodeficient mice Proc. Natl. Acad. Sci. U. S. A. 89 1992 4481 4485
54. R. Sun, H. Wei, J. Zhang, A. Li, W. Zhang, and Z. Tian Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo Neuroimmunomodulation 10 2003 169 176